A Single-Center, Randomized, Investigator/Subject-Blind, Adaptive Single-Ascending-Dose(SAD), Placebo-Controlled, Parallel Study to Investigate the Safety, Tolerability, Pharmacokinetics (Including the Effect of Food and the Effect of Itraconazole on the Pharmacokinetics of a Single Oral Dose of RO7034067), and Pharmacodynamics of RO7034067 Following Oral Administration in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 03 Mar 2017
At a glance
- Drugs RG 7916 (Primary) ; Itraconazole
- Indications Spinal muscular atrophy
- Focus Adverse reactions
- Sponsors Roche
- 01 Sep 2016 Status changed from active, no longer recruiting to completed.
- 01 Jun 2016 Planned End Date changed from 1 Aug 2016 to 1 Sep 2016.
- 01 Jun 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Sep 2016.